Showing results (771-780 of 823) with videos related to

Sort By:
Pageof 83
Experimental & Molecular Medicine|October 28, 2021
Comprehensive profiles and diagnostic value of menopausal-specific gut microbiota in premenopausal breast cancerMing-Feng Hou, Fu Ou-Yang, Chung-Liang Li, et al.
Neuroimage|June 29, 2019
Neurovascular decoupling in type 2 diabetes mellitus without mild cognitive impairment: Potential biomarker for early cognitive impairmentYing Yu, Lin-Feng Yan, Qian Sun, et al.
Neuroimage. Clinical|April 18, 2019
Disturbed neurovascular coupling in type 2 diabetes mellitus patients: Evidence from a comprehensive fMRI analysisBo Hu, Lin-Feng Yan, Qian Sun, et al.
BMJ (Clinical Research Ed.)|December 23, 2025
Effect of adjuvant carboplatin intensified chemotherapy versus standard chemotherapy on survival in women with high risk, early stage, triple negative breast cancer (CITRINE): randomised, open label phase 3 trialYin Liu, Yue Gong, Xiu-Zhi Zhu, et al.
NPJ Precision Oncology|February 6, 2026
Adipocyte-driven STAT3-ANGPT2-PTGIS axis promotes cutaneous metastasis in breast cancer and represents a targetable pathwayChi-Wen Luo, Fu Ou-Yang, Shu-Jyuan Chang, et al.
Cancer Genomics & Proteomics|January 2, 2026
Comparative Transcriptomic Analysis Identifies Predictive Biomarkers of Pathological Complete Response in Triple-negative Breast CancerFang-Ming Chen, Chung-Liang Li, Mei-Ren Pan, et al.
Plos One|November 3, 2017
Multi-center study on patient selection for and the oncologic safety of intraoperative radiotherapy (IORT) with the Xoft Axxent® eBx® System for the management of early stage breast cancer in TaiwanHung-Wen Lai, Liang-Chih Liu, Fu Ouyang, et al.
Journal for Immunotherapy of Cancer|July 29, 2020
Globo H-KLH vaccine adagloxad simolenin (OBI-822)/OBI-821 in patients with metastatic breast cancer: phase II randomized, placebo-controlled studyChiun-Sheng Huang, Alice L Yu, Ling-Ming Tseng, et al.
Oncology Research and Treatment|July 21, 2024
Comparison of the Efficacy, Safety, and Quality of Life of Pegylated Liposomal Doxorubicin-Cyclophosphamide versus Epirubicin-Cyclophosphamide in Patients with Early-Stage HER2-Negative Breast Cancer: A Prospective, Randomized, Multicenter, Phase II StudyLing-Ming Tseng, Fang Ming Chen, Shou-Tung Chen, et al.
Breast Cancer Research and Treatment|April 7, 2018
Effect of eribulin on patients with metastatic breast cancer: multicenter retrospective observational study in TaiwanKun-Ming Rau, Fu Ou-Yang, Ta-Chung Chao, et al.
Pageof 83